prnewswire.comIllimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform5 days ago
prnewswire.comGAIA Study Reveals Groundbreaking Links Between Nutrition, Mental Resilience, and Infectious Disease Recovery4 months ago
businesswire.comAI is Only 30% Away From Matching Human-Level General Intelligence on GAIA Benchmark7 months ago
prnewswire.comSupporting Health Equity: EpiVax Highlights Partnerships and New Research from Clnica Esperanza and GAIA Vaccine Foundation7 months ago
finance.yahoo.comGaia’s HEAL Conference Hosted by Kelly Gores and Headlined by Medical Medium, Anthony William, to Take Place at GaiaSphere Event Center on November 9-10, 20249 months ago
CashuIllimis Therapeutics Secures Funding to Enhance GAIA Platform for Neuro-Immune Disease Treatments3 days ago
CashuGaia Platform Powers Illimis Therapeutics' Advances in Alzheimer's and Immune Disorder Treatments5 days ago
CashuIllimis Therapeutics Secures Funding to Advance GAIA Platform for Neuro-Immune Disease Treatments7 days ago